Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

EGFR and HER-2 tyrosine kinase inhibitors with in vivo antitumor activity reported

Aug. 22, 2001

Combretastatin significantly potentiates the antitumor action of radioimmunotherapy

Aug. 22, 2001

Selective CDK4 inhibitors for the treatment of proliferative diseases identified at Lilly

Aug. 21, 2001

E.C approves DepoCyte for treatment of lymphomatous meningitis

Aug. 21, 2001

Atrix licenses Leuprogel Depot products in Australia and New Zealand

Aug. 21, 2001

Study of AVI BioPharma's third-generation antisense technology to begin

Aug. 21, 2001

Mechanism of action of ecteinascidin 743 shown to involve nucleotide excision repair

Aug. 21, 2001

Pilot study of thalidomide in myelodysplastic syndrome yields encouraging results

Aug. 21, 2001

Phase I study successful for Prescient NeuroPharma's anhydrovinblastine

Aug. 20, 2001

Geron and Kyowa Hakko select telomerase inhibitor for development

Aug. 20, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...